Primary study · included by 1 review
Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial.
Umpreecha 2023 · Umpreecha Chalapinyo, Bhalang Kanokporn, Charnvanich Dusadee, et al. · BMC complementary medicine and therapies · 2023
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.